Indica Labs: Learn How HALO Macrodissection Solutions Quantifies Tumor Content and Guides ROI Selection
Indica Labs: HALO Macrodissection Solutions harness the power of AI to quantify and visualize tumor content to improve the reliability of downstream molecular testing in lung, colorectal, breast, and prostate cancers.
Accurate estimation of tumor content is a critical step in preparing tissue samples for downstream molecular analysis. Variability in manual assessment can affect the selection of regions for macrodissection and influence the reliability of subsequent molecular analyses. Indica Labs’ HALO Macrodissection Solutions apply AI-driven image analysis to quantify tumor content and guide region-of-interest selection in lung, colorectal, breast, and prostate cancers. By supporting consistent tumor enrichment prior to molecular testing, these tools help laboratories establish streamlined workflows that bridge anatomic pathology and molecular diagnostics. The company’s new brochure outlines the capabilities of these solutions, including validation data, output metrics, and workflow considerations. Download the brochure to learn more about how AI-powered digital pathology can support your macrodissection workflows.
Reach out to Indica at info@indicalab.com with any questions or to learn more!
SOURCE: Indica Labs
